Sumedha Vats, Anchal Tripathi, Inam Danish Khan, Pawan Dhull, Sanjay Kumar Mishra, Ranjit Goenka, Devendra Paul Vats
{"title":"一次性低浓度倍他丁洗眼液:治疗流行性病毒性结膜炎的新疗法,可加速康复。","authors":"Sumedha Vats, Anchal Tripathi, Inam Danish Khan, Pawan Dhull, Sanjay Kumar Mishra, Ranjit Goenka, Devendra Paul Vats","doi":"10.22336/rjo.2024.49","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to renew the management of viral epidemic conjunctivitis by introducing a one-time, low-concentration ocular surface povidone-iodine (LOS-pI) wash.</p><p><strong>Methods: </strong>Among the 3,002 patients screened, 1,328 with acute conjunctivitis were categorized into two groups. Group A (664 patients) underwent a 1% betadine wash in addition to the standard treatment protocol (Eye Lubricant + Moxifloxacin 0.5% eyedrops), while Group B (664 patients) followed the standard protocol alone. In cases of membranous conjunctivitis, manual membrane removal was performed. Treatment responses were observed daily for three days, followed by weekly assessments for two additional weeks.</p><p><strong>Results: </strong>Co-infection of adenovirus with enterovirus was found to be the main cause, often accompanied by staphylococcal superinfection. Group A showed complete resolution of conjunctival inflammation, with a remarkable 76.05% of patients experiencing improvement within an average of 2.6±0.51 days, in contrast to Group B's average of 7.5±1.1 days (p <0.05). Additionally, 13% of Group B patients with recalcitrant conjunctivitis significantly recovered following the 1% betadine wash. Complications (subconjunctival hemorrhage: 34.04%, superficial punctate keratitis: 6.02%) were more prevalent in Group B.</p><p><strong>Discussion: </strong>The authors hypothesized that a single wash with betadine is sufficient to reduce disease duration and prevent secondary infections and complications. The core strength of our study lies in its substantial sample size. To our knowledge, no similar previous research has been conducted, on such a larger scale.</p><p><strong>Conclusion: </strong>Viral conjunctivitis brings discomfort, work absenteeism, and financial burden. A single low-concentration betadine wash expedites recovery and reduces complications in acute infective conjunctivitis. This approach significantly enhances patient outcomes and alleviates the socioeconomic impact of the condition.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"68 3","pages":"268-273"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503237/pdf/","citationCount":"0","resultStr":"{\"title\":\"One-time low concentration betadine eye wash: A novel treatment for epidemic viral conjunctivitis for accelerated recovery.\",\"authors\":\"Sumedha Vats, Anchal Tripathi, Inam Danish Khan, Pawan Dhull, Sanjay Kumar Mishra, Ranjit Goenka, Devendra Paul Vats\",\"doi\":\"10.22336/rjo.2024.49\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aims to renew the management of viral epidemic conjunctivitis by introducing a one-time, low-concentration ocular surface povidone-iodine (LOS-pI) wash.</p><p><strong>Methods: </strong>Among the 3,002 patients screened, 1,328 with acute conjunctivitis were categorized into two groups. Group A (664 patients) underwent a 1% betadine wash in addition to the standard treatment protocol (Eye Lubricant + Moxifloxacin 0.5% eyedrops), while Group B (664 patients) followed the standard protocol alone. In cases of membranous conjunctivitis, manual membrane removal was performed. Treatment responses were observed daily for three days, followed by weekly assessments for two additional weeks.</p><p><strong>Results: </strong>Co-infection of adenovirus with enterovirus was found to be the main cause, often accompanied by staphylococcal superinfection. Group A showed complete resolution of conjunctival inflammation, with a remarkable 76.05% of patients experiencing improvement within an average of 2.6±0.51 days, in contrast to Group B's average of 7.5±1.1 days (p <0.05). Additionally, 13% of Group B patients with recalcitrant conjunctivitis significantly recovered following the 1% betadine wash. Complications (subconjunctival hemorrhage: 34.04%, superficial punctate keratitis: 6.02%) were more prevalent in Group B.</p><p><strong>Discussion: </strong>The authors hypothesized that a single wash with betadine is sufficient to reduce disease duration and prevent secondary infections and complications. The core strength of our study lies in its substantial sample size. To our knowledge, no similar previous research has been conducted, on such a larger scale.</p><p><strong>Conclusion: </strong>Viral conjunctivitis brings discomfort, work absenteeism, and financial burden. A single low-concentration betadine wash expedites recovery and reduces complications in acute infective conjunctivitis. This approach significantly enhances patient outcomes and alleviates the socioeconomic impact of the condition.</p>\",\"PeriodicalId\":94355,\"journal\":{\"name\":\"Romanian journal of ophthalmology\",\"volume\":\"68 3\",\"pages\":\"268-273\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503237/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Romanian journal of ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22336/rjo.2024.49\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian journal of ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22336/rjo.2024.49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究旨在通过引入一次性低浓度眼表聚维酮-碘(LOS-pI)清洗,更新病毒性流行性结膜炎的治疗方法:在接受筛查的 3 002 名患者中,1 328 名急性结膜炎患者被分为两组。A组(664 名患者)在标准治疗方案(眼部润滑剂+0.5%莫西沙星眼药水)的基础上进行了 1%倍他定清洗,而 B 组(664 名患者)仅按照标准方案进行了清洗。如果出现膜性结膜炎,则进行人工除膜。每天观察治疗反应三天,然后每周评估一次,连续两周:结果:腺病毒与肠道病毒混合感染是主要原因,通常伴有葡萄球菌超级感染。A 组结膜炎症完全消退,76.05% 的患者在平均 2.6±0.51 天内病情明显好转,而 B 组平均为 7.5±1.1 天(P 讨论):作者假设,用倍他丁清洗一次就足以缩短病程并预防继发感染和并发症。我们研究的核心优势在于样本量大。据我们所知,此前还没有进行过如此大规模的类似研究:病毒性结膜炎会带来不适、旷工和经济负担。单次低浓度倍他丁清洗可加快急性感染性结膜炎患者的康复并减少并发症。这种方法大大提高了患者的治疗效果,减轻了病情对社会经济的影响。
One-time low concentration betadine eye wash: A novel treatment for epidemic viral conjunctivitis for accelerated recovery.
Purpose: This study aims to renew the management of viral epidemic conjunctivitis by introducing a one-time, low-concentration ocular surface povidone-iodine (LOS-pI) wash.
Methods: Among the 3,002 patients screened, 1,328 with acute conjunctivitis were categorized into two groups. Group A (664 patients) underwent a 1% betadine wash in addition to the standard treatment protocol (Eye Lubricant + Moxifloxacin 0.5% eyedrops), while Group B (664 patients) followed the standard protocol alone. In cases of membranous conjunctivitis, manual membrane removal was performed. Treatment responses were observed daily for three days, followed by weekly assessments for two additional weeks.
Results: Co-infection of adenovirus with enterovirus was found to be the main cause, often accompanied by staphylococcal superinfection. Group A showed complete resolution of conjunctival inflammation, with a remarkable 76.05% of patients experiencing improvement within an average of 2.6±0.51 days, in contrast to Group B's average of 7.5±1.1 days (p <0.05). Additionally, 13% of Group B patients with recalcitrant conjunctivitis significantly recovered following the 1% betadine wash. Complications (subconjunctival hemorrhage: 34.04%, superficial punctate keratitis: 6.02%) were more prevalent in Group B.
Discussion: The authors hypothesized that a single wash with betadine is sufficient to reduce disease duration and prevent secondary infections and complications. The core strength of our study lies in its substantial sample size. To our knowledge, no similar previous research has been conducted, on such a larger scale.
Conclusion: Viral conjunctivitis brings discomfort, work absenteeism, and financial burden. A single low-concentration betadine wash expedites recovery and reduces complications in acute infective conjunctivitis. This approach significantly enhances patient outcomes and alleviates the socioeconomic impact of the condition.